SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001367644-23-000173
Filing Date
2023-10-05
Accepted
2023-10-05 19:01:41
Documents
4
Period of Report
2023-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1696546891.html 3  
1 FORM 3 wk-form3_1696546891.xml 3 2201
2 EX-24 ddegolyer_poa.htm EX-24 6076
3 ddegolyer_poa001.jpg GRAPHIC 231533
4 ddegolyer_poa002.jpg GRAPHIC 101445
  Complete submission text file 0001367644-23-000173.txt   468336
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 PROFESSIONAL DR. STE. 400 GAITHERSBURG MD 20879
Business Address
DeGolyer Donald W (Reporting) CIK: 0001583098 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33137 | Film No.: 231312386